Sazan Anwar

Associate, Stockholm

Corporate Advisory, Equity Capital Markets, Public M&A

Contact

Sazan Anwar is a Stockholm-based Associate and a member of Roschier’s Public M&A, Equity Capital Markets and Corporate Advisory practices. She joined Roschier in 2023.

Work highlights

Sazan Anwar’s experience includes advising:

  • CVC in the recommended cash offer for Resurs Holding;
  • A bid consortium consisting of Greenoaks and Long Path in their recommended public offer for Karnov;
  • Avalara in its SEK 7.3 billion public offer for Pagero;
  • TA Associates in the fully underwritten SEK 4.3 billion rights issue in Elos Medtech;
  • Frazier Life Sciences in its investment in Egetis Therapeutics.
Career

Roschier (2023-)

Education

Örebro University, LL.M. (2023)

Languages

English, Kurdish, Swedish, Turkish